In a phase 1 trial, Novo Nordisk's experimental obesity drug amycretin led to up to 13% weight loss in just three months.

LOTTIE Moss has bravely opened up about her struggles with body image, which at one point saw her go on Ozempic. It’s the ...

Halia plans to advance HT-6184 into a Phase 2 clinical trial for obesity later this year. This trial will evaluate the safety, tolerability, and efficacy of HT-6184 in combination with semaglutide for ...

Researchers from the University of Liverpool have found that the weight-loss drug tirzepatide could significantly reduce the ...

Skye launched its Phase 2 trial of nimacimab in obesity in August 2024. This trial, which is the first to also assess a GLP-1/CB1 inhibitor combination, is expected to report interim weight loss data ...

Located at 150 Pine Forest Drive, Ste. 603, Shenandoah, the practice specializes in weight loss with an emphasis on the use of GLP-1 medications, a class of drugs that help regulate appetite and blood ...

Compounded semaglutide has emerged as a significant development in the management of obesity and type 2 diabetes. As a ...

Prescription weight loss drugs have become so popular in the United States that suppliers have struggled to keep up.

An exciting new Irish study has found that Semaglutide, the substance found in popular weight-loss drugs Ozempic and Wegovy, ...

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...